In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Veracyte Inc (NASDAQ: VCYT) closed the day trading at $28.49 down -2.80% from the previous closing price of $29.31. In other words, the price has decreased by -$2.80 from its previous closing price. On the day, 1.36 million shares were traded. VCYT stock price reached its highest trading level at $29.76 during the session, while it also had its lowest trading level at $28.34.
Ratios:
For a better understanding of VCYT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.44. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 5.10. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On December 05, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $38 to $37.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Leite John sold 7,411 shares for $31.66 per share. The transaction valued at 234,630 led to the insider holds 100,249 shares of the business.
JOHN LEITE bought 7,411 shares of VCYT for $240,932 on Mar 07 ’25. On Mar 04 ’25, another insider, ANN MCGUIRE, who serves as the Officer of the company, bought 1,142 shares for $33.56 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 2231182848 and an Enterprise Value of 1994329216. As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 67.91, and their Forward P/E ratio for the next fiscal year is 40.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.81 while its Price-to-Book (P/B) ratio in mrq is 1.87. Its current Enterprise Value per Revenue stands at 4.304 whereas that against EBITDA is 32.022.
Stock Price History:
The Beta on a monthly basis for VCYT is 2.14, which has changed by 0.21752131 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $19.73. The 50-Day Moving Average of the stock is -8.02%, while the 200-Day Moving Average is calculated to be -18.91%.
Shares Statistics:
Over the past 3-months, VCYT traded about 1.08M shares per day on average, while over the past 10 days, VCYT traded about 1391420 shares per day. A total of 78.31M shares are outstanding, with a floating share count of 76.08M. Insiders hold about 2.86% of the company’s shares, while institutions hold 109.96% stake in the company. Shares short for VCYT as of 1745971200 were 5566844 with a Short Ratio of 5.17, compared to 1743379200 on 4165854. Therefore, it implies a Short% of Shares Outstanding of 5566844 and a Short% of Float of 7.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
